AR084703A1 - Dispositivos oftalmicos que contienen antagonistas de quimocina - Google Patents

Dispositivos oftalmicos que contienen antagonistas de quimocina

Info

Publication number
AR084703A1
AR084703A1 ARP110102337A ARP110102337A AR084703A1 AR 084703 A1 AR084703 A1 AR 084703A1 AR P110102337 A ARP110102337 A AR P110102337A AR P110102337 A ARP110102337 A AR P110102337A AR 084703 A1 AR084703 A1 AR 084703A1
Authority
AR
Argentina
Prior art keywords
antagonists
chemocine
ophthalmic devices
devices containing
methods
Prior art date
Application number
ARP110102337A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR084703A1 publication Critical patent/AR084703A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente describe dispositivos oftálmicos iónicos, métodos para tratar condiciones inflamatorias mediadas por antagonistas del receptor 2 de citocina quimioatrayente (CCR2) y métodos para fabricar tales dispositivos.
ARP110102337A 2010-06-30 2011-06-30 Dispositivos oftalmicos que contienen antagonistas de quimocina AR084703A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35996310P 2010-06-30 2010-06-30

Publications (1)

Publication Number Publication Date
AR084703A1 true AR084703A1 (es) 2013-06-05

Family

ID=44501773

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102337A AR084703A1 (es) 2010-06-30 2011-06-30 Dispositivos oftalmicos que contienen antagonistas de quimocina

Country Status (13)

Country Link
US (1) US20120004298A1 (es)
EP (1) EP2588049A2 (es)
JP (1) JP2013536457A (es)
KR (1) KR20130083900A (es)
CN (1) CN102958508A (es)
AR (1) AR084703A1 (es)
AU (1) AU2011279992A1 (es)
BR (1) BR112012033657A2 (es)
CA (1) CA2803368A1 (es)
RU (1) RU2013103784A (es)
SG (1) SG186474A1 (es)
TW (1) TW201206424A (es)
WO (1) WO2012012184A2 (es)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS108895A (es) 1961-12-27
NL128305C (es) 1963-09-11
US4197266A (en) 1974-05-06 1980-04-08 Bausch & Lomb Incorporated Method for forming optical lenses
US4113224A (en) 1975-04-08 1978-09-12 Bausch & Lomb Incorporated Apparatus for forming optical lenses
US4495313A (en) 1981-04-30 1985-01-22 Mia Lens Production A/S Preparation of hydrogel for soft contact lens with water displaceable boric acid ester
US4680336A (en) 1984-11-21 1987-07-14 Vistakon, Inc. Method of forming shaped hydrogel articles
US4691820A (en) 1985-11-18 1987-09-08 Vistakon, Inc. Package for hydrophilic contact lens
US4889664A (en) 1988-11-25 1989-12-26 Vistakon, Inc. Method of forming shaped hydrogel articles including contact lenses
NZ250453A (en) 1992-12-21 1996-12-20 Johnson & Johnson Vision Prod Ophthalmic lens package; planar surface with concave bowl for containing lens, sealing sheet covering bowl with lens therein
US5823327A (en) 1993-11-02 1998-10-20 Johnson & Johnson Vision Products, Inc. Packaging arrangement for contact lenses
US5696686A (en) 1994-06-10 1997-12-09 Johnson & Johnson Vision Products, Inc. Computer system for quality control correlations
US5577367A (en) 1994-06-10 1996-11-26 Johnson & Johnson Vision Products, Inc. Apparatus and method for sterilization and secondary packaging
US5488815A (en) 1994-06-10 1996-02-06 Johnson & Johnson Vision Products, Inc. Apparatus and method for sterilization and secondary packaging
US5704468A (en) 1995-09-29 1998-01-06 Johnson & Johnson Vision Products, Inc. Packaging arrangement for contact lenses
US6277365B1 (en) * 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6018931A (en) 1998-09-08 2000-02-01 Johnson & Johnson Vision Products, Inc. Method and support for supporting packages only at their edges during steam sterilization
US6050398A (en) 1998-11-25 2000-04-18 Novartis, Ag Contact lens storage container
USD435966S1 (en) 1999-01-29 2001-01-09 Johnson & Johnson Vision Care, Inc. Contact lens container
US20040091613A1 (en) * 2002-11-13 2004-05-13 Wood Joe M. Methods for the extraction of contact lenses
JP4379778B2 (ja) * 2003-04-03 2009-12-09 株式会社シード 薬物徐放性眼用レンズ
EP1765803B1 (en) * 2004-06-25 2016-03-09 Janssen Pharmaceutica NV Quaternary salt ccr2 antagonists
JP2010524017A (ja) * 2007-03-30 2010-07-15 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド 膨張剤を使用した、ヘーズの低減した抗菌コンタクトレンズの作成
US10105441B2 (en) * 2007-08-16 2018-10-23 The Schepens Eye Research Institute, Inc. Method for inhibiting or reducing dry eye disease by IL-1Ra
CA2711696C (en) * 2008-01-09 2021-10-26 Reza Dana Therapeutic compositions for treatment of ocular inflammatory disorders
US8470906B2 (en) 2008-09-30 2013-06-25 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels having improved hydrolytic stability

Also Published As

Publication number Publication date
CA2803368A1 (en) 2012-01-26
WO2012012184A3 (en) 2012-11-15
WO2012012184A2 (en) 2012-01-26
TW201206424A (en) 2012-02-16
SG186474A1 (en) 2013-02-28
CN102958508A (zh) 2013-03-06
AU2011279992A1 (en) 2013-01-10
RU2013103784A (ru) 2014-08-10
BR112012033657A2 (pt) 2016-11-29
US20120004298A1 (en) 2012-01-05
JP2013536457A (ja) 2013-09-19
KR20130083900A (ko) 2013-07-23
EP2588049A2 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
CL2016001983A1 (es) Compuestos aza bicíclicos como agonistas del receptor muscarínico m1 y/o m4
UY34832A (es) TIAZOLES SUSTITUIDOS POR CARBOXAMIDA O SULFONAMIDA Y DERIVADOS RELACIONADOS COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUÉRFANO RORy (lambda)
UY4276Q (es) Controlador para dispositivo electrónico
MX2021002406A (es) Composiciones farmaceuticas que comprenden un inhibidor de il-4r para usarse en el tratamiento de la esofagitis eosinofilica.
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
CO6930356A2 (es) Compuestos inhibidores de metaloenzimas
CY1120219T1 (el) Ανταγωνιστες της il17c για τη θεραπευτικη αντιμετωπιση φλεγμονωδων διαταραχων
UY4275Q (es) Controlador para dispositivo electrónico
NZ737399A (en) Ccr2 modulators
UY34833A (es) Heterociclos de 5 miembros que contienen nitrógeno sustituidos por carboxamida o sulfonamida como moduladores para el receptor nuclear huérfano RORy
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34824A (es) Nucleósidos de espirooxetano de uracilo
JOP20140141B1 (ar) استخدام 3،2- ثنائي هيدروإيميدازول-[2،1-c] كونازولينات مستبدلة لمعالجة الاورام الليمفاوية
UY33910A (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del SNC
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
UY34615A (es) Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias.
CL2016002240A1 (es) Derivados de piperidina como antagonista de receptores de orexina
DOP2014000114A (es) Nuevos 2h–indazoles como antagonistas del receptor ep2
TW201612160A (en) Compounds as CRTH2 antagonist and uses thereof
MX2012014983A (es) Quinolinas como inhibidores pi3k.
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
CL2015000469A1 (es) Composición para su utilización como plasma de control anormal de la coagulación en ensayos in vitro
AR084703A1 (es) Dispositivos oftalmicos que contienen antagonistas de quimocina
CO7400866A2 (es) Anticuerpos anti-receptor de procineticinas (prokr) y usos de los mismos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal